Skip to main content
Erschienen in: Intensive Care Medicine 7/2019

20.05.2019 | Editorial

SUPERNOVA: will its energy trigger the formation of a new therapeutic star?

verfasst von: Thomas Bein, Audrey De Jong, Anders Perner

Erschienen in: Intensive Care Medicine | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Excerpt

In 1983, Luciano Gattinoni had the vision of a ‘motionless lung’ [1] with the help of an extracorporeal carbon dioxide elimination concept. At that time the term VILI (ventilator induced lung injury) was still far beyond the horizon and no intensivist or respiratory therapist anticipated the consequences of the ARDS Network study from 2000 [2], which began to hold a mirror up to the intensive care community in terms of a protective approach to the injured lung. Did no intensivist or respiratory therapist really anticipate this? The answer is just a few around Gattinoni who stated in 1978 “that patients treated with mechanical ventilation ultimately die, either of the underlying disease process or of complications of pulmonary therapy with mechanical ventilation” [3]. In the late 1990s, a long and partly successful story began on lung protective strategies aimed at saving lives by preventing the deleterious effects of artificial ventilation. Why only partly successful? The answer seems simple, but it is not: the reduction of tidal volume and inspiratory pressure levels was helpful, but it was not the definitive solution to the dilemma between the necessity of mechanical ventilation (to guarantee a life-saving gas exchange) and the attenuation of its harmful effects. In other words, the low tidal volume strategy combined with a limitation of inspiratory pressures went in the right direction, but the clinical scientists continued to ask: “Is there a safe upper limit to inspiratory plateau pressure in patients with ALI/ARDS?” [4]. …
Literatur
1.
Zurück zum Zitat Gattinoni L, Pesenti A, Kolobow T, Damia G (1983) A new look at therapy of the adult respiratory distress syndrome: motionless lungs. Int Anesthesiol Clin 21(2):97–117CrossRefPubMed Gattinoni L, Pesenti A, Kolobow T, Damia G (1983) A new look at therapy of the adult respiratory distress syndrome: motionless lungs. Int Anesthesiol Clin 21(2):97–117CrossRefPubMed
2.
Zurück zum Zitat Acute Respiratory Distress Syndrome Network, Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308CrossRef Acute Respiratory Distress Syndrome Network, Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308CrossRef
3.
Zurück zum Zitat Gattinoni L, Kolobow T, Tomlinson T, Iapichino G, Samaja M, White D, Pierce J (1978) Low-frequency positive pressure ventilation with extracorporeal carbon dioxide removal (LFPPV-ECCO2R): an experimental study. Anesth Analg 57(4):470–477CrossRefPubMed Gattinoni L, Kolobow T, Tomlinson T, Iapichino G, Samaja M, White D, Pierce J (1978) Low-frequency positive pressure ventilation with extracorporeal carbon dioxide removal (LFPPV-ECCO2R): an experimental study. Anesth Analg 57(4):470–477CrossRefPubMed
4.
Zurück zum Zitat Hager DN, Krishnan JA, Hayden DL, Brower RG, ARDS Clinical Trials Network (2005) Tidal volume reduction in patients with acute lung injury when plateau pressures are not high. Am J Respir Crit Care Med 172(10):1241–1245CrossRefPubMedPubMedCentral Hager DN, Krishnan JA, Hayden DL, Brower RG, ARDS Clinical Trials Network (2005) Tidal volume reduction in patients with acute lung injury when plateau pressures are not high. Am J Respir Crit Care Med 172(10):1241–1245CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, Hibbert CL, Truesdale A, Clemens F, Cooper N, Firmin RK, Elbourne D, CESAR Trial Collaboration (2009) Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 374(9698):1351–1363CrossRef Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, Hibbert CL, Truesdale A, Clemens F, Cooper N, Firmin RK, Elbourne D, CESAR Trial Collaboration (2009) Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 374(9698):1351–1363CrossRef
6.
Zurück zum Zitat Karagiannidis C, Brodie D, Strassmann S, Stoelben E, Philipp A, Bein T, Müller T, Windisch W (2016) Extracorporeal membrane oxygenation: evolving epidemiology and mortality. Intensive Care Med 42:889–896CrossRefPubMed Karagiannidis C, Brodie D, Strassmann S, Stoelben E, Philipp A, Bein T, Müller T, Windisch W (2016) Extracorporeal membrane oxygenation: evolving epidemiology and mortality. Intensive Care Med 42:889–896CrossRefPubMed
7.
Zurück zum Zitat Morelli A, Del Sorbo L, Pesenti A, Ranieri VM, Fan E (2017) Extracorporeal carbon dioxide removal (ECCO2R) in patients with acute respiratory failure. Intensive Care Med 43:519–530CrossRefPubMed Morelli A, Del Sorbo L, Pesenti A, Ranieri VM, Fan E (2017) Extracorporeal carbon dioxide removal (ECCO2R) in patients with acute respiratory failure. Intensive Care Med 43:519–530CrossRefPubMed
8.
Zurück zum Zitat Karagiannidis C, Kampe KA, Sipmann FS, Larsson A, Hedenstierna G, Windisch W, Mueller T (2014) Veno-venous extracorporeal CO2 removal for the treatment of severe respiratory acidosis: pathophysiological and technical considerations. Crit Care 18:R124CrossRefPubMedPubMedCentral Karagiannidis C, Kampe KA, Sipmann FS, Larsson A, Hedenstierna G, Windisch W, Mueller T (2014) Veno-venous extracorporeal CO2 removal for the treatment of severe respiratory acidosis: pathophysiological and technical considerations. Crit Care 18:R124CrossRefPubMedPubMedCentral
9.
10.
Zurück zum Zitat Schultz MJ, Juffermans NP, Matthay MA (2013) From protective ventilation to super-protective ventilation for acute respiratory distress syndrome. Intensive Care Med 39:963–965CrossRefPubMedPubMedCentral Schultz MJ, Juffermans NP, Matthay MA (2013) From protective ventilation to super-protective ventilation for acute respiratory distress syndrome. Intensive Care Med 39:963–965CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Bein T, Weber-Carstens S, Goldmann A, Müller T, Staudinger T, Brederlau J, Muellenbach R, Dembinski R, Graf BM, Wewalka M, Philipp A, Wernecke KD, Lubnow M, Slutsky AS (2013) Lower tidal volume strategy (≈ 3 ml/kg) combined with extracorporeal CO2 removal versus 'conventional' protective ventilation (6 ml/kg) in severe ARDS: the prospective randomized Xtravent-study. Intensive Care Med 39:847–856CrossRefPubMedPubMedCentral Bein T, Weber-Carstens S, Goldmann A, Müller T, Staudinger T, Brederlau J, Muellenbach R, Dembinski R, Graf BM, Wewalka M, Philipp A, Wernecke KD, Lubnow M, Slutsky AS (2013) Lower tidal volume strategy (≈ 3 ml/kg) combined with extracorporeal CO2 removal versus 'conventional' protective ventilation (6 ml/kg) in severe ARDS: the prospective randomized Xtravent-study. Intensive Care Med 39:847–856CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Combes A, Fanelli V, Pham T, Ranieri VM, European Society of Intensive Care Medicine Trials Group, and the “Strategy of Ultra-Protective lung ventilation with Extracorporeal CO2 Removal for New-Onset moderate to severe ARDS” (SUPERNOVA) Investigators (2019) Feasibility and safety of extracorporeal CO2 removal to enhance protective ventilation in acute respiratory distress syndrome: the SUPERNOVA study. Intensive Care Med. https://doi.org/10.1007/s00134-019-05567-4 CrossRefPubMed Combes A, Fanelli V, Pham T, Ranieri VM, European Society of Intensive Care Medicine Trials Group, and the “Strategy of Ultra-Protective lung ventilation with Extracorporeal CO2 Removal for New-Onset moderate to severe ARDS” (SUPERNOVA) Investigators (2019) Feasibility and safety of extracorporeal CO2 removal to enhance protective ventilation in acute respiratory distress syndrome: the SUPERNOVA study. Intensive Care Med. https://​doi.​org/​10.​1007/​s00134-019-05567-4 CrossRefPubMed
14.
Zurück zum Zitat Beitelshees AL, Voora D, Lewis JP (2015) Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics. Pharmgenomics Pers Med 8:43–61PubMedPubMedCentral Beitelshees AL, Voora D, Lewis JP (2015) Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics. Pharmgenomics Pers Med 8:43–61PubMedPubMedCentral
Metadaten
Titel
SUPERNOVA: will its energy trigger the formation of a new therapeutic star?
verfasst von
Thomas Bein
Audrey De Jong
Anders Perner
Publikationsdatum
20.05.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 7/2019
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-019-05641-x

Weitere Artikel der Ausgabe 7/2019

Intensive Care Medicine 7/2019 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.